Aged Rats and Mice for Cognitive Decline Research

Charles River conducts contract studies in established animal models of cognitive decline associated with aging (including Alzheimer’s disease) to test the efficacy of novel therapeutics. Our aged rat and mouse models begin to exhibit cognitive, biochemical and brain metabolism deficits at approximately 20 months of age. Aged cohorts of animals are available for immediate studies.

Aged rat and mouse studies can also be combined with scopolamine-induced amnesia.

  • Body weight
  • Morris Water Maze (MWM) for learning and memory
  • In vivo 1H-MR spectroscopy for hippocampal metabolic profiling
  • Synaptophysin qPCR for synaptic marker
  • Synaptic
    • qPCR for PSD95
    • Synaptophysin IHC/WB
  • Bioenergetic, Mitochondrial and Redox
    • In vitro 31P-MRS for ATP, ADP, PCR, Pi
    • In vitro 1H-MRS for PCR, CR, NAA, TAU, GLU, GLN, LAC, GABA, mINS, ACE, CHO and GSH
  • Neurochemical
    • HPLC for ACh, DA, 5HT, NE
  • Cell Population and Proliferation
    • Immunohistochemistry for NeuN, GFAP and Iba-1
    • BrdU

You may also be interested in...

In Vivo Alzheimer's Disease Models

Charles River's Alzheimer's disease platform includes transgenic CVN and Tg2576 mice, which display pathologies associated with Alzheimer's disease.

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.